Investment Range
~$50M – $450M USD (est.)Estimated — modeled from this fund's AUM or comparable lenders, not confirmed by the fund. Counts for less than a confirmed range in match scoring.
Deal Types
Equity
Sectors
Healthcare, Technology, Energy, Real Estate, Media/Telecom, Mining & Resources
Geographies
Global, North America, Europe
AUM
$18B
Headquarters
New York, NY, United States
OrbiMed is a leading healthcare-dedicated investment firm with a global presence. They invest across the spectrum of healthcare companies, from early-stage private companies to large-cap public companies.
ElevateBio, ReCode Therapeutics, Theseus Pharmaceuticals, Acelyrin, Apellis Pharmaceuticals
Unlock full contacts
Reveal 2 deal-team contacts at OrbiMed Advisors, LLC — emails, LinkedIn, titles (permanent on your account).
Email bounces? Forward to deals@agentasllc.com — we re-credit within a business day. Unlock is private; your info is never sold. Sign in first — the unlock stays on your account.
Profile and contact information is compiled from public sources and TerraNova's own research. It is not provided or endorsed by the fund, and accuracy is not guaranteed.
Short deal overview → banker reviews → warm intro, typically within one business day.
Investment Range
$150M – $775M USD
Investment Range
~$50M – $2B USD (est.)
Estimated — awaiting the fund's own figure
Investment Range
$200M – $2B USD
Match your deal against the full lender book — free to search.